鄭彩梅(Zheng, Cai-Mei) 教授

Email
d118102005@tmu.edu.tw
現   職
內科學科 教授
共同儀器中心 副主任

學經歷

學 歷

畢業學校與學位[修業時間]
臺北醫學大學臨床醫學研究所 博士
2015/08~2019/06
仰光第一醫學院醫學系 學士
1993/07~2000/07

本校學術經歷

任職單位與職稱[起迄時間]
內科學科教授
2024/08/01~
內科學科副教授
2021/08/01~2024/07/31
內科學科助理教授
2018/08/01~2021/07/31
內科學科講師
2015/08/01~2018/07/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
共同儀器中心副主任
2023/08/01 ~

其它經歷

任職單位與職稱[起迄時間]
雙和醫院腎臟內科專任主治醫師
雙和醫院內科部住院醫師
2011/02~2013/09/31
耕莘醫院新店醫院內科住院醫師總醫師
2007/08~2011/01
耕莘醫院永和分院內科助理
2005/08~2006/07
緬甸kanpelet醫院內科住院醫師
2003/10~2004/10
緬甸景東醫院內科住院醫師
2001/11~2003/09
緬甸仰光第一醫學中心實習醫師
2000/07~2001/07

專長與研究領域

學門領域
學術專長

論文著作

清冊下載


1. 2024 Kuo-Cheng Lu . Potential role of molecular hydrogen therapy on oxidative stress and redox signaling in chronic kidney disease. Biomed Pharmacother . Biomed Pharmacother .2024

2. 2024 Lin YF,Lin CW, Chen YC, Sun CA, Chen JT. . The Association between Diabetic Retinopathy and Macular Degeneration: A Nationwide Population-Based Study. . Biomedicines .2024

3. 2024 Yun-Hsiang Chang, Jiann-Torng Chen, Jing-Quan Zheng3,12,13, Ming-Cheng Tai, Yu-Han Huang, Yuh-Feng Lin, Hsin-Ting Lin. Effect of spectacle correction on hyperopic children . International Journal of Medical Sciences .2024

4. 2024 Lu KC. Potential role of molecular hydrogen therapy on oxidative stress and redox signaling in chronic kidney disease. . Biomed Pharmacother .2024

5. 2024 Lu KC,,Chu CM,Chang YT. Sleep Duration and Kidney Function - Does Weekend Sleep Matter? . Nat Sci Sleep. .2024

6. 2024 Lu KC. Resveratrol Mitigates Uremic Toxin-Induced Intestinal Barrier Dysfunction in Chronic Kidney Disease by Promoting Mitophagy and Inhibiting Apoptosis Pathways. . Int J Med Sci. .2024

7. 2024 Evaluating the Effectiveness of a Novel Personalized Health Education Approach for Hemodialysis Patients: A Four-Week Study Using a Widely-Used Communication App in Taiwan. . Stud Health Technol Inform .2024

8. 2024 Chiu HW.. Polystyrene microplastic-induced extracellular vesicles cause kidney-related effects in the crosstalk between tubular cells and fibroblasts. . Ecotoxicol Environ Saf. .2024

9. 2024 Chiu YJ,Zheng CM . Etelcalcetide ameliorates bone loss in chronic kidney disease-mineral and bone disorder by activation of IRF7 and necroptosis pathways. . .Int J Biol Macromol .2024

10. 2023 Zheng CM. Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor. . Comput Struct Biotechnol J .2023

11. 2023 Tseng MM,Chien LN,Tu CY, Zheng CM,Liu HY. Risk of dialysis and renal diseases in patients with anorexia nervosa in Taiwan . Int J Eat Disord .2023

12. 2023 Hou Y-C ,Liu Y-M,Liao M-T ,Zheng C-M,Lu C-L,Liu W-C, Hung K-C, Lin S-M, Lu K-C. Indoxyl sulfate mediates low handgrip strength and is predictive of high hospitalization rates in patients with end-stage renal disease . Front. Med .2023

13. 2023 Chia-Wei Lin1,2, Jing-Quan Zheng3-5, Kai-Yi Tzou1,2,6, Yu-Ann Fang7,8, Wei- 5 Tang Kao1,2,6, Hsin-Ting Lin9,10, Ju-Chi Liu3,7,8,11, Yu-Han Huang12, Yuh-Feng 6 Lin3,10,13,14, Kuo-Cheng Lu15, Shao-Wei Dong1,2, Cai-Mei Zheng 3,13-14*, Chia- 7 Chang Wu. Chia-Wei Lin1,2, Jing-Quan Zheng3-5, Kai-Yi Tzou1,2,6, Yu-Ann Fang7,8, Wei- 5 Tang Kao1,2,6, Hsin-Ting Lin9,10, Ju-Chi Liu3,7,8,11, Yu-Han Huang12, Yuh-Feng 6 Lin3,10,13,14, Kuo-Cheng Lu15, Shao-Wei Dong1,2, Cai-Mei Zheng 3,13-14*, Chia- 7 Chang Wu . Clinical Kidney Journal .2023

14. 2023 Chia-Wei Lin1,2, Jing-Quan Zheng3-5, Kai-Yi Tzou1,2,6, Yu-Ann Fang7,8, Wei- 5 Tang Kao1,2,6, Hsin-Ting Lin9,10, Ju-Chi Liu3,7,8,11, Yu-Han Huang12, Yuh-Feng 6 Lin3,10,13,14, Kuo-Cheng Lu15, Shao-Wei Dong1,2, Cai-Mei Zheng 3,13-14*, Chia- 7 Chang Wu1. 1 Influenza Vaccination is Associated with Lower Risk of Renal Cell Carcinoma 2 among Chronic Kidney Disease Patients: A Population-Based Cohort Study . Clinical Kidney Journal .2023

15. 2023 Huang HJ, Lee YH, Sung LC, Chen YJ, Chiu YJ, Chiu HW, Zheng CM. . Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor. .2023

16. 2023 Zheng CM,Chiu HW. Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety. . Biomolecules .2023

17. 2023 Indoxyl sulfate induced frailty in patients with end-stage renal disease by disrupting the PGC-1α-FNDC5 axis . Aging .2023

18. 2023 Fang YA, Hao WR, Chen CC, Yang TY, Lee KY, Liu JC. Effect of Annual Influenza Vaccination on the Risk of Lung Cancer Among Patients With Hypertension: A Population-Based Cohort Study in Taiwan. . Int J Public Health .2023

19. 2023 Hsu CC, Wu MS, Chuang SY. Transitions of dialysis status and outcomes after the unplanned first dialysis: a nationwide population-based cohort study . Sci Rep .2023

20. 2022 Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease. . Pharmaceuticals (Basel) .2022

21. 2022 Uremic Toxin Indoxyl Sulfate Impairs Hydrogen Sulfide Formation in Renal Tubular Cells . Antioxidants (Basel) .2022

22. 2022 Chang JF, Zheng CM. . Cinacalcet Improves Bone Parameters Through Regulation of Osteoclast Endoplasmic Reticulum Stress, Autophagy, and Apoptotic Pathways in Chronic Kidney Disease-Mineral and Bone Disorder . J Bone Miner Res .2022

23. 2022 Li-Ching Ma ,Yueh-Min Liu,Yen-Chung Lin,Chia-Te Liao,Kuo-Chin Hung,Remy Chen. Factors Influencing Self-Management Behaviors among Hemodialysis Patients. . J. Pers. Med .2022

24. 2022 Su, P.-C.,Zheng, C.-M.,Chen, C.-C.,Chiu, L.-Y.. Effect of Dialysis Modalities on All-Cause Mortality and Cardiovascular Mortality in End-Stage Kidney Disease: A Taiwan Renal Registry Data System (TWRDS) 2005–2012 Study. . J. Pers. Med .2022

25. 2022 Chen, Y. W.,Wu, M. Y.,Mao, C. H.,Yeh, Y. T.,Chen, T. T.,Liao, C. T., Zheng, C. M.. Severe acute kidney disease is associated with worse kidney outcome among acute kidney injury patients. . Scientific Reports .2022

26. 2022 Lin YC,Liao CT, Zheng CM,Lin MH,Hsu CC,Hsu YH, Wu MS. Clinical characteristics and outcomes of patients requiring incident dialysis in Taiwan. . J Formos Med Assoc .2022

27. 2022 Investigation of potential descriptors of chemical compounds on prevention of nephrotoxicity via QSAR approach . Computational and Structural Biotechnology Journal .2022

28. 2022 Wu MY, Lin YF, Liao CT, Hung YP, Tsai CC, Cherng YG, Wu MS. Allogeneic adipose tissue-derived stem cells ELIXCYTE® in chronic kidney disease: A phase I study assessing safety and clinical feasibility. . J Cell Mol Med .2022

29. 2022 Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy. . Biomed Pharmacother .2022

30. 2021 Chang SW, Wang TM, Wu CC.. Circulating p-Cresyl Sulfate, Non-Hepatic Alkaline Phosphatase and Risk of Bone Fracture Events in Chronic Kidney Disease-Mineral Bone Disease . Toxins (Basel) .2021

31. 2021 Yi-Chou Hou, Kuo-Cheng Lu, You-Chen Chao. . Putative Role of Vitamin D for COVID-19 Vaccination . Int J Mol Sci .2021

32. 2021 Jenn-Yeu Song, Kuo-Cheng Lu, You-Chen Chao. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D. . Int J Mol Sci .2021

33. 2021 The Role of Plasma Neurofilament Light Protein for Assessing Cognitive Impairment in Patients With End-Stage Renal Disease. . Front Aging Neurosci. .2021

34. 2021 Effect of Profit Status in Facilities on Mortality Among Patients with Long-term Hemodialysis: A Nationwide Cohort Study. . BMJ Open .2021

35. 2021 Dong-Feng Yeih. Primary prevention of cardiovascular disease events with renin-angiotensin system blockade in autosomal dominant polycystic kidney disease dialysis patients: A nationwide cohort study. . Medicine (Baltimore). .2021

36. 2021 Ting-Ying Liao, Yin-Cheng Chen, Kuo-Cheng Lu.. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis. . Int J Mol Sci .2021

37. 2021 Chu CM, Chang YT. . Sleeping, Smoking, and Kidney Diseases: Evidence From the NHANES 2017-2018. . Front Med (Lausanne) .2021

38. 2021 Jiann-Torng Chen,Chang-Min Liang,Tian-Jong Chang,Jing-Quan Zheng,Ming-Cheng Tai, Yuh-Feng Lin. Prevalence and risk factors for myopia in Taiwanese diabetes mellitus patients: A multicenter case–control study in Taiwan . Scientific Reports .2021

39. 2021 Lu CL, Zheng CM, Lu KC, Liao MT, Wu KL, Ma MC. Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease. Antioxidants (Basel). 2021 Jun 9;10(6):936. doi: 10.3390/antiox10060936. PMID: 34207816; PMCID: PMC8228088. . Antioxidants (Basel) .2021

40. 2021 Jenn-Yeu Song, Kuo-Cheng Lu, and You-Chen Chao. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D . Int. J. Mol. Sci. .2021

41. 2021 Therapeutic Effect of Endothelin-Converting Enzyme Inhibitor on Chronic Kidney Disease through the Inhibition of Endoplasmic Reticulum Stress and the NLRP3 Inflammasome. . Biomedicine 2021, 9, 398. .2021

42. 2021 Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease. . Antioxidants (Basel) .2021

43. 2021 Micro- and Nanosized Substances Cause Different Autophagy-Related Responses . Int. J. Mol. Sci. .2021

44. 2021 Zheng CM, Lu KC, Chao YC. Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy . Int J Med Sci .2021

45. 2021 Hsu CC, Wu MS. Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients . Sci Rep. .2021

46. 2020 Chiu IJ, Syu RS, Wang TM, Wu CC, Hung LY, Zheng CM, Lu KC.. Therapeutic Effect of Calcimimetics on Osteoclast-Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease . Int J Mol Sci .2020

47. 2020 Lo YL, Lu KC, Hsu YH, Wang YH.. Influence of intradialytic systolic blood pressure changes on arteriovenous access thrombosis in maintenance hemodialysis patients . Int J Clin Pract .2020

48. 2020 Chen KC, Peng CC, Lin YF, Hsu CC, Wu MS, Lin YC . The modulating effect of dietary protein intake on mortality in long-term hemodialysis patients: A nationwide population-based study . Int J Clin Pract .2020

49. 2020 Chiu HW. Nicotine Causes Nephrotoxicity through the Induction of NLRP6 Inflammasome and Alpha7 Nicotinic Acetylcholine Receptor. . Toxics .2020

50. 2020 Hou YC, Liu WC, Lu CL. . Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease. . Toxins (Basel). .2020

51. 2020 Zheng CM, Hou YC, Chen PH, Lu KC.. Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway. . Int J Mol Sci .2020

52. 2020 Lin CC, Wu CC, Ka SM, Wen LL, Wu MS, Zheng CM, Ko WC.. Scavenging Intracellular ROS Attenuates p-Cresyl Sulfate-Triggered Osteogenesis through MAPK Signaling Pathway and NF-κB Activation in Human Arterial Smooth Muscle Cells. . Toxins (Basel). .2020

53. 2020 Hou YC, Wu CC, Lin YF, Lu KC. Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor. . Int J Mol Sci .2020

54. 2020 Chao CT, Lu KC, Ng YY. . Sirtuin-1 and its relevance in vascular calcification. . Int J Mol Sci .2020

55. 2020 Lin YF, Chao CT, Lu KC. The Role of Vitamin D in Modulating Mesenchymal Stem Cells and Endothelial Progenitor Cells for Vascular Calcification. . Int J Mol Sci .2020

56. 2020 Sirtuin-1 and Its Relevance in Vascular Calcification . Int. J. Mol. Sci .2020

57. 2020 Sirtuin-1 and Its Relevance in Vascular Calcification . Int. J. Mol. Sci .2020

58. 2020 Yuh-Feng Lin,Chia-Ter Chao,Kuo-Cheng Lu. The Role of vitamin D in modulating mesenchymal 2 stem cells and endothelial progenitor cells for 3 vascular calcification . Int. J. Mol. Sci .2020

59. 2020 Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection . Int J Mol Sci .2020

60. 2020 Novel Evidence of Acute Kidney Injury in COVID-19 . J Clin Med .2020

61. 2020 Po-Jui Chen,Bo-Hau Chen,† Cai-Mei Zheng,† and Kuo-Cheng Lu. Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease . Int J Mol Sci .2020

62. 2020 Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus . J Clin Med .2020

63. 2019 2. Hou YC, Lu CL, Zheng CM, Chen RM, Lin YF, Liu WC, Yen TH, Chen R, Lu KC. . Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification. .2019

64. 2019 Zheng CM,Wang JY,Chen TT,Wu YC,Wu YL,Lin HT, Chiu SP, Chang TJ, Zheng JQ, Chu NF, Lin YM, Su SL, Lu KC, Chen JS, Sung FC, Lee CT, Yang Y, Hwang SJ, Wang MC, Hsu YH, Chiou HY, Kao S, Wu MY*, Lin YF*. Angiotensin converting inhibitors or angiotensin receptor blocker monotherapy retards renal function deterioration in Taiwanese chronic kidney disease population . Scientific Reports .2019 ;(Accepted):1-14

65. 2019 Hsin-Ting Lin,Cai-Mei Zheng,Yun-Chun Wu,Yun-Hsiang Chang,Jiann-Torng Chen,Chang-Min Liang. Diabetic Retinopathy as a Risk Factor for Chronic Kidney Disease Progression: A Multicenter Case–Control Study in Taiwan . Nutrients .2019 ;(11):1-11

66. 2019 Yi-Chou Hou,Chien-Lin Lu,Cai-Mei Zheng,Ruei-Ming Chen,Yuh-Feng Lin,Wen-Chih Liu. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification . Nutrients .2019 ;(11):1-13

67. 2019 Remy Chen,Tian Jong Chang,Jia Fwu Shyu,Yuh Feng Lin,Kuo Cheng Lu. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients . International Journal of Medical Sciences .2019

68. 2019 Yuh Feng Lin ,Hui Wen Chiu ,Tian Jong Chang,Jia Fwu Shyu,Kuo Cheng Lu. Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease . International Journal of Molecular Science .2019

69. 2019 Cai Mei Zheng,Chia Chao Wu,Chien Lin Lu,Yi Chou Hou,Mai Szu Wu,Yung Ho Hsu, Remy Chen, Tian Jong Chang, Jia Fwu Shyu, Yuh Feng Lin, Kuo Cheng Lu. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients . International Journal of Medical Sciences .2019 ;(12):眨1583-1592

70. 2018 Zheng CM. Lu CL, Shyu JF, Wu CC, Hung CF, Liao MT, Liu WC, Zheng CM , Hou YC, Lin YF16, Lu KC . Association of Anabolic Effect of Calcitriol with Osteoclast-Derived Wnt 10b Secretion. .2018

71. 2018 Shyu JF, Lin YF, Lu KC.. Effect of uremic toxin-indoxyl sulfate on the skeletal system. . Clin Chim Acta .2018

72. 2018 Zheng CM, Lin YF, Shyu JF, Chen R, Huang CY, Lu KC.. The emerging role of nutritional vitamin D in secondary hyperparathyroidism in ckd . Nutrients. .2018

73. 2018 Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients . Nutrients .2018 ;(10(2))

74. 2018 Chang TJ ,Zheng CM,Wu MY,Chen TT, Wu YC,Wu YL, Lin HT, Zheng JQ, Chu NF, Lin YM, Su SL, Lu KC, Chen JS, Sung FC, Lee CT, Yang Y, Hwang SJ, Wang MC, Hsu YH, Chiou HY, Kao S, Lin YF. Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population . Scientific Reports .2018

75. 2017 Chen CH,Chen TH,Wu MY,Chou TC,Chen JR,Wei MJ. Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice . Scientific Reports .2017 ;(10)

76. 2017 Cheng Mei-Mei,Zheng Jing-quan,Zheng Cai-Mei,Wu Chia-Chao,Huang Ming-Te,Lin Yuh-Feng, Lu Kuo-Cheng. Association between Anion Gap and Strong Ion Gap in Commonly Encountered Acid-Base Disorders among Critically Ill Patients . Journal of Urology and Renal Diseases .2017

77. 2017 Zheng JQ,Zheng CM,Lu KC. Corosolic acid-induced acute kidney injury and lactic acidosis in a patient with impaired kidney function. . Am J Kidney Dis. 2010; 56(2):419-20. .2017

78. 2017 Chang LC, Lin YF.. Atorvastatin from target screening attenuates endothelial cell tube formation and migration by regulating urokinase receptor-related signaling pathway and F/G actin. . J Chin Med Assoc. .2017

79. 2017 Role of Vitamin D in Uremic Vascular Calcification. . Biomed Res Int. .2017

80. 2017 Zheng Jing Quan ,Lai Hui Ju ,Zheng Cai Mei ,Yen Yu Chun ,Lu Kuo Cheng . Association of stroke subtypes with risk of hip fracture: a population-based study in Taiwan . Archives of Osteoporosis .2017 ;(12)

81. 2016 Lu CL,Leu JG,Wen-Chih Liu,Cai-Mei Zheng,Yuh-Feng Lin,Jia-Fwu Shyu, Chia-Chao Wu, Kuo-Cheng Lu. Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis Patients . Int. J. Med. Sci. 2016; 13(3): 240-247 .2016

82. 2016 Jing-Quan Zheng,,Yi-Chou Hou,Cai-Mei Zheng,Chien-Lin Lu,Wen-Chih Liu,Chia-Chao Wu Ming-Te Huang Yuh-Feng Lin Kuo-Cheng Lu. Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients. . Nutrients. 2016 Nov 5;8(11). pii: E708. .2016

83. 2016 Zheng CM,Zheng JQ,Wu CC,Lu CL,Shyu JF,Yung HH Wu MY Chiu IJ Wang YH Lin YF Lu KC. Bone loss in chronic kidney disease: Quantity or Quality? . Bone .2016

84. 2016 Shen CH,Zheng CM,Kiu KT,Chen HA,Wu CC,Lu KC HsuYH Lin YF Wang YH. Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan . medicine .2016

85. 2015 Chen CH,Chen TH,Wu MY,Chen JR,Tsai HF,Hong LY, Zheng CM, Chiu IJ, Lin YF, Hsu YH. Peroxisome proliferator-activated receptor alpha protects renal tubular cells from gentamicin-induced apoptosis via upregulating Na+/H+ exchanger NHE1. . Mol Med. 2015 Nov 23. doi: 10.2119/molmed.2015.00196 .2015

86. 2015 Liu WC,Zheng CM,Lu CL,Lin YF,Shyu JF,Wu CC, Lu KC.. Vitamin D and immune function in chronic kidney disease . Clin Chim Acta. 2015 Oct 23;450:135-44. .2015

87. 2014 Lin YF,Sheng LH,Wu MY,Zheng CM,Chang TJ,Li YC, Huang YH, Lu HP.. A study of renal function influence by integrating cloud-based manometers and physician order entry systems. . J Chin Med Assoc. 2014;77:642-647. .2014

88. 2014 Pei-Chen Wu,Cai-Mei Zheng,Min-Tser Liao,Chia-Chao Wu,Kuo-Cheng Lu,Wen-Chih Liu. Bone Turnover and Vascular Calcification. . J Nephrol Ther. 2014;4(4):1000171 .2014

89. 2014 Zheng CM,Liu WC,Zheng JQ,Liao MT,Ma WY,Hung KC, Lu CL, Wu CC, Lu KC. Metabolic acidosis and strong ion gap in critically ill patients with acute kidney injury. . Biomed Res Int. 2014;2014:819528 .2014

90. 2013 Lin YF,Lin YM,Sheng LH,Chien HY,Chang TJ,Zheng CM, Lu HP.. First Drive-through Pharmacy Services in Taiwan. . J Chin Med Assoc. 2013 Jan;76(1):37-41. .2013

91. 2013 Cai-Mei Zheng,Min-Tser Liao,Mei-Yu Lin,Lan Lo,Chia-Chao Wu,Yung-Ho Hsu, Yuh-Feng Lin, Kuo-Cheng. Biomarkers in acute kidney injury. . Open Journal of Nephrology. 2013;3:51-60 .2013

92. 2012 Wu CC,Zheng CM,Lin YF,Lo L,Liao MT,Lu KC. Role of homocysteine in end-stage renal disease. Clin Biochem. . Clin Biochem. 2012 Nov;45(16-17):1286-94. .2012

93. 2012 Zheng CM,Ma WY,Wu CC,Lu KC. Glycated albumin in diabetic patients with chronic kidney disease. . Clin Chim Acta. 2012; 9;413(19-20):1555-61. .2012

94. 2012 Zheng CM,Chu P,Wu CC,Ma WY,Hung KC,Hsu YH, Lin YF, Diang LK, Lu KC.. Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. . Tohoku J Exp Med. 2012;226(1):19-27 .2012

95. 2012 Jin-Shuen Chen,Cai-Mei Zheng,Ching-Feng Huang,Shih Hua Lin,Pauling Chu,Huey Kang Sytwu, Yuh Feng Lin, Chia Chao Wu. Immunomodulatory therapy using recombinant IFN-γ revealed opposite effects in different stages of experimental murine membranous nephropathy. . Journal of Medical Sciences. 2012;32(6):287-295. .2012

96. 2012 Huang CY,Zheng CM,Wu CC,Lo L,Lu KC,Chu P. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism. . Nephron Clin Pract. 2012;122(3-4):93-101. .2012

97. 2011 Cai-Mei Zheng,Kuo-Cheng Lu,Chia-Chao Wu,Hsu YH,Lin YF. Association of Serum Phosphate and Related Factors in ESRD-related vascular calcification. . Int J Nephrol. 2011: 939613. Epub 2011 May 25. .2011

98. 2011 Wu CC,Chang JH,Chen CC,Su SB,Yang LK,Ma WY, Zheng CM, Diang LK, Lu KC.. Calcitriol treatment attenuates inflammation and oxidative stress in hemodialysis patients with secondary hyperparathyroidism. . Tohoku J Exp Med. 2011;223(3):153-9. .2011

99. 2010 Cai-Mei Zheng,Kuo-Cheng Lu,Jing-Quan Zheng,Jung-Mou Yang. Evaluation of Acid-Base Disorders in Two Patients Using Stewart’s Approach. . J Emerg Crit Care Med. 21:1; P1 - 9 .2010

研究計畫

計畫名稱
112 Etelcalcetide經由調控DUSP4和TRAF3路徑於慢性腎臟疾病-礦物質骨病變可改善硫酸吲哚酚引起的低骨轉換率(3/3)
補助單位
國家科學及技術委員會

計畫名稱
111 Etelcalcetide經由調控DUSP4和TRAF3路徑於慢性腎臟疾病-礦物質骨病變可改善硫酸吲哚酚引起的低骨轉換率(2/3)
補助單位
國家科學及技術委員會

計畫名稱
111 貴機構(內科鄭彩梅副教授)延攬黃泓縉君參與「Etelcalcetide經由調控DUSP4和TRAF3路徑於慢性腎臟疾病-礦物質骨病變可改善硫酸吲哚酚引起的低骨轉換率」研究計畫案,申請本會補助,業經核定以「博士級研究人員」資格補助(NSTC 111-2811-B-038-024)
補助單位
國家科學及技術委員會

計畫名稱
110 Etelcalcetide經由調控DUSP4和TRAF3路徑於慢性腎臟疾病-礦物質骨病變可改善硫酸吲哚酚引起的低骨轉換率
補助單位
科技部

計畫名稱
110 Etelcalcetide經由調控DUSP4和TRAF3路徑於慢性腎臟疾病-礦物質骨病變可改善硫酸??酚引起的低骨轉換率(1/3)
補助單位
科技部

計畫名稱
109 Etelcalcetide經由調控Nrf2和Klotho-AMPK路徑改善腎性骨病變的骨轉換、血管鈣化和腎臟纖維化
補助單位
科技部

計畫名稱
108 探討salubrinal通過抑制內質網壓力和自體吞噬作用來改善腎性骨病變和血管鈣化的研究
補助單位
科技部

計畫名稱
107 在腎性骨病變模式中擬鈣劑通過調節內質網壓力和自體吞噬作用來改善骨病變之研究
補助單位
科技部

計畫名稱
102 探討microRNA494與活化轉錄因子3的關係及在肥胖引糖尿病發腎病變中所扮演之生理角色
補助單位
衛生福利部雙和醫院(委託臺北醫學大學興建經營)